Gelonghui August 24 丨Qizheng Tibetan Pharmaceutical (002287.SZ) announced its 2023 semi-annual report. Operating income for the reporting period was 829.8 million yuan, down 7.48% year on year; net profit attributable to shareholders of listed companies was 312 million yuan, up 34.41% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 218 million yuan, down 11.32% year on year; basic earnings per share were 0.5893 yuan.
奇正藏药(002287.SZ)：上半年净利增34.41%至3.12亿元
Qizheng Tibetan Medicine (002287.SZ): Net profit increased by 34.41% in the first half of the year to 312 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.